Pill Picks

A Pharmacist's Investing Point of View

Skip to content
  • Pill Picks
  • Drug Approval Dates
  • About the Author
  • Contact
Search

Month: June 2019

Seattle Genetics (NASDAQ: SGEN)

June 19, 2019July 11, 2019 / PillPicks / Leave a comment

Seattle Genetics is an attractive short term swing trade. The company currently has an approved product, ADCETRIS® (brentuximab vedotin), and focuses on antibody-drug conjugate technology. Click to read more about my technical analysis and ADC technology.

Arena Pharmaceuticals (NASDAQ: ARNA)

June 8, 2019June 10, 2019 / PillPicks / Leave a comment

Arena Pharmaceuticals, is a company I see value in. The company’s leading pipeline is etrasimod, in which its worldwide Phase 3 trial for the treatment of moderately to severely active ulcerative colitis is currently in the planning process. Click the title of the post to read more.

PillPicks Twitter

My Tweets

Enter your email address to follow this blog and receive notifications of new posts by email.

Archives

  • June 2022
  • February 2021
  • March 2020
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019

Categories

Create a website or blog at WordPress.com
Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookie Policy
  • Follow Following
    • Pill Picks
    • Already have a WordPress.com account? Log in now.
    • Pill Picks
    • Customize
    • Follow Following
    • Sign up
    • Log in
    • Report this content
    • View site in Reader
    • Manage subscriptions
    • Collapse this bar
 

Loading Comments...